Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Efatutazone, an Oral PPAR Agonist, In Comb W/Paclitaxel In Pts W/ Advan Anaplastic Thyroid Ca.

Protocol: ALLIANCE-A091305

Full Title

Phase II Study Of Efatutazone, an Oral PPAR Agonist, In Combination With Paclitaxel In Patients With Advanced Anaplastic Thyroid Cancer.

Head & Neck Cancers